1993
DOI: 10.1006/bbrc.1993.1144
|View full text |Cite
|
Sign up to set email alerts
|

Tyrosine Kinase Inhibitors Suppress Agonist-Induced Contraction in Smooth Muscle

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

5
72
2

Year Published

1995
1995
2006
2006

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 159 publications
(79 citation statements)
references
References 0 publications
5
72
2
Order By: Relevance
“…In the present study, genistein and tyrphostin 23 showed a differential inhibitory effect on the acidic pH , PE-, and KCl-induced contractions, that is, the drugs inhibited the acidic pH and PE-induced contractions markedly compared with that induced by KCl. Similar relaxant effects of tyrosine kinase inhibitors, including tyrphostin 23 and genistein, on a variety of agonists-induced contractions in vascular tissues have been reported through inhibition of tyrosine kinases (Di Salvo et al, 1993;Jin et al, 1996;Watts et al, 1996;Yang et al, 2000b;Carmines et al, 2001). …”
Section: Downloaded Fromsupporting
confidence: 62%
See 1 more Smart Citation
“…In the present study, genistein and tyrphostin 23 showed a differential inhibitory effect on the acidic pH , PE-, and KCl-induced contractions, that is, the drugs inhibited the acidic pH and PE-induced contractions markedly compared with that induced by KCl. Similar relaxant effects of tyrosine kinase inhibitors, including tyrphostin 23 and genistein, on a variety of agonists-induced contractions in vascular tissues have been reported through inhibition of tyrosine kinases (Di Salvo et al, 1993;Jin et al, 1996;Watts et al, 1996;Yang et al, 2000b;Carmines et al, 2001). …”
Section: Downloaded Fromsupporting
confidence: 62%
“…Tyrosine kinase-mediated pathways have also been shown to cause agonist-stimulated VSM contractile processes (Khalil et al, 1995;Banes et al, 1999). Consistently, tyrosine kinase inhibitors have been shown to attenuate vasoconstriction caused by a number of agents, including noradrenaline and angiotensin II in intact arteries (Di Salvo et al, 1993Laniyonu et al, 1994;Carmines et al, 2001). Recent studies have shown that the voltage-dependent Ca 2ϩ channels (VDCCs), activated by many vasoactive agents, are inhibited by tyrosine kinase inhibitors via tyrosine kinases (Wijetunge et al, 1992;Wijetunge et al, 1998;Lagaud et al, 1999).…”
mentioning
confidence: 93%
“…This observation is consistent with the fact that phosphorylation of tyrosyl residues by tyrosine kinase is implicated in the mechanisms leading to constriction of vascular smooth muscle [18][19][20][21][22]. Vasoconstriction occurs as a result of activation of myosin light chain kinase (MLCK) that, in turn, phosphorylates myosin light chain, thereby enabling formation of actin-myosin cross bridges resulting in vascular smooth muscle contraction [23].…”
Section: Discussionsupporting
confidence: 78%
“…However, studies with platelets (30,31,34), fibroblasts (20), and colonic smooth muscle (10,13) have suggested that depletion of intracellular calcium stores induces calcium influx across the plasma membrane via a PTK-dependent mechanism. Moreover, inhibitors of PTKs have been shown to inhibit contractions of isolated bronchioles of the rat (9).…”
Section: Discussionmentioning
confidence: 99%